Showing results (311-320 of 422) with videos related to

Sort By:
Pageof 43
Mayo Clinic Proceedings|September 20, 2021
Eosinophils in Health and Disease: A State-of-the-Art ReviewMichael E Wechsler, Ariel Munitz, Steven J Ackerman, et al.
Respiratory Medicine|December 17, 2025
Evolution and factors associated with presenteeism in severe asthma after treatment with biologicsJustine Subocz, Thomas Stoup, Jonathan Giovannelli, et al.
The Journal of Allergy and Clinical Immunology. Global|June 12, 2026
The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammationWilliam W Busse, Melissa Iammatteo, Mena Soliman, et al.
The European Respiratory Journal|November 5, 2021
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registryAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
ERJ Open Research|August 5, 2025
Association of positive airway pressure adherence with use of antihypertensive drugs in patients with sleep apnoeaDany Jaffuel, Erika Nogue, François Roubille, et al.
American Journal of Respiratory Cell and Molecular Biology|June 6, 2024
Cell Culture Differentiation and Proliferation Conditions Influence the In Vitro Regeneration of the Human Airway EpitheliumElisa Redman, Morgane Fierville, Amélie Cavard, et al.
Rheumatology (Oxford, England)|February 2, 2023
In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre studyBenjamin Chaigne, Kevin Chevalier, Athenaïs Boucly, et al.
Respiratory Research|May 11, 2018
Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)Julie Bulsei, Sylvie Leroy, Jeanne-Marie Perotin, et al.
The New England Journal of Medicine|September 13, 2017
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary DiseaseIan D Pavord, Pascal Chanez, Gerard J Criner, et al.
The Lancet. Respiratory Medicine|November 29, 2025
Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trialDavid J Jackson, Njira L Lugogo, Mark Gurnell, et al.
Pageof 43